-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Collegium Pharmaceutical, Inc annual/quarterly Current Federal Tax Expense (Benefit) history and growth rate from 2020 to 2021.
- Collegium Pharmaceutical, Inc Current Federal Tax Expense (Benefit) for the quarter ending March 31, 2021 was $0.000.
- Collegium Pharmaceutical, Inc annual Current Federal Tax Expense (Benefit) for 2023 was $21.5 M, a 12854% increase from 2022.
Current Federal Tax Expense (Benefit), Quarterly (USD)